Scientists have detected that a previously overlooked gene behavior could potentially lead to a new way to diagnose Alzheimer’s earlier.
Published in the journal Epigenetics, an international research team’s findings—discovered in mice and confirmed in human samples—suggest that the gene Presenilin1 (PSEN1) should be monitored as a ‘biomarker’: to see what environmental triggers, such as lifestyle and nutrition, can influence brain function and neurodegeneration or/and to see how well the body responds to a treatment for the disease.
Led by Professor Andrea Fuso at the Sapienza University of Rome, the study is the first to observe that the methylation (when the DNA…
